Physician profile
Daus Mahnke
NPI 1306878566
$2,252.25
in general payments reported to CMS, 2019-2025
16 companies · $500 in 2025
The $500 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.22 · 2020: $154 · 2021: $235 · 2022: $362 · 2023: $488 · 2024: $450 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086 · Grant: $335 · Debt Forgiveness: $17.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,085.72 |
| Grant | $335.00 |
| Debt Forgiveness | $17.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,103.13 | 2020-2025 | |
| Celgene Corporation | $357.38 | 2021-2024 | Zeposia |
| Gilead Sciences, INC. | $163.78 | 2023-2025 | |
| Janssen Biotech, INC. | $132.08 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.53 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.96 | 2021-2023 | Entyvio |
| Intercept Pharmaceuticals, INC. | $53.90 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $49.01 | 2023-2024 | Dupixent |
| Qol Medical, LLC | $44.13 | 2019-2021 | |
| Capsovision, INC. | $36.29 | 2025 | Capsocam Plus |
| Lilly USA, LLC | $23.12 | 2025 | Omvoh |
| Nestle Healthcare Nutrition INC. | $20.79 | 2022 | |
| Merck Sharp & Dohme LLC | $18.82 | 2022 | |
| Pfizer INC. | $18.12 | 2023 | |
| Olympus America INC. | $17.69 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $14.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daus Mahnke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.